23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV

随着抗逆转录病毒疗法(Art)的成功，共病现在是主要原因。 全球艾滋病毒携带者的死亡和残疾情况，包括中低收入 国家(LMIC)。大型会议，如逆转录病毒和机会主义会议 传染病和国际艾滋病协会会议，是科学研究的重要场所 关于艾滋病毒共病研究的最新进展的交流，但规模更小，更亲密 强调讨论和联系的形式对艾滋病毒的职业发展至关重要 共病调查员。合并症与药品不良反应国际研讨会 艾滋病毒的反应，现已进入第23个年头，为200名代表提供了一个即将到来的机会 一起在一个房间里讨论艾滋病毒共病研究的最新发现和争议， 两天制。全体演讲者要么是艾滋病毒研究领域以外的知名专家，要么是艾滋病毒 在一种特定的合并症方面有专长的研究人员。摘要演示文稿包括24个15- 会议纪要和海报会议为研究人员提供了充分的机会来介绍和获得 对他们最新工作的反馈。通过此R13，我们建议增强第23次研讨会(10月 25/26在伦敦)，目的如下：1)为最新的艾滋病毒共病提供一个论坛 通过向LMIC调查人员提供旅行奖学金，支持LMIC的研究 LMIC国际公认的非传染性疾病专家作为全体发言人， 并与国际培训计划联系，2)为早期调查人员提供支持 奖学金计划和职业发展工作室，以及有导游的海报之旅，3)增加 通过全体会议和摘要发言的网播，提高讲习班的影响力。通过 为来自中国的越来越多的艾滋病毒共病调查人员提供“科学之家” 在世界各地，我们希望促进未来在艾滋病毒并存方面的研究努力，并促进 将研究成果转化为临床策略，可以延长寿命和 PLWH的健康寿命。

With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes of death and disability in people living with HIV around the globe, including low and middle income countries (LMIC). Large meetings, such as the Conference for Retroviruses and Opportunistic Infections and the International AIDS Society Conference, are important venues for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate formats,that emphasize discussion and networking are critical to the career development of HIV Comorbidity investigators. The International Workshop for Comorbidities and Adverse Drug Reactions in HIV, now in its 23rd year, provides <200 delegates with an opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity research in one-room, two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV researchers with expertise in a specific comorbidity. Abstract presentations including 24 15- minute talks and a poster session provide ample opportunity for researchers to present and get feedback on their latest work. With this R13, we propose to enhance the 23rd Workshop (October 25th/26th in London) with the following aims: 1) to provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC investigators, supporting an internationally-recognized expert in non-communicable diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to support early-stage investigators with a scholarship program and a Career Development Studio, and guided poster tour, 3) to increase the impact of the Workshop through the webcast of plenary and abstract presentations. By providing a “scientific home” to an increasing number of HIV Comorbidity investigators from around the world, we hope to catalyze future research efforts in HIV Comorbidities and facilitate the translation of research findings into clinical strategies that can improve the lifespan and healthspan of PLWH.